Skip to Content


In the US, Dexlansoprazole (dexlansoprazole systemic) is a member of the drug class proton pump inhibitors and is used to treat Barrett's Esophagus, Erosive Esophagitis and GERD.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Gastric acid secretion inhibitor

Treatment of peptic ulcer and gastro-oesophageal reflux disease (GORD)

Proton pump inhibitor (PPI)

Chemical Names

(+)-2-[(R)-{[3-metyl-4-(2,2,2-trifluoroetoxy)pyridin-2-yl]metyl}sulfinyl]-1H-benzamidazole (WHO)

1H-Benzimidazole, 2-[(R)-[[3-metyl-4-(2,2,2-trifluoroetoxy)-2-pyridinyl]metyl]-sulfinyl]- (USAN)

Foreign Names

  • Dexlansoprazolum (Latin)
  • Dexlansoprazol (German)
  • Dexlansoprazole (French)
  • Dexlansoprazol (Spanish)

Generic Names

  • Dexlansoprazole (OS: USAN)
  • T-168390 (IS)
  • TAK-390 (IS)
  • TAK-390 MR (IS)
  • UNII-UYE4-T5I70X (IS)

Brand Names

  • Dexilant
    Takeda, Germany; Takeda, United States; Takeda Canada, Canada; Takeda Pharma, Switzerland
  • Dexivant
    Takeda, Mexico
  • Dexlan
    Ibn Sina, Bangladesh

International Drug Name Search


ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.